Objective
Blood is the essential physiological parameter when it comes to assess our health, going from routine check-ups to complex
tests for infectious diseases. Each step in the process of the blood draw affects the quality of the specimen and is thus
important for preventing laboratory error, patient injury and even death. E.g. the touch of a finger to verify the location of a
vein before insertion of the needle increases the chance that a specimen will be contaminated. This can cause false blood
culture results, prolong hospitalization, delay diagnosis and cause unnecessary use of antibiotics.
A total of 2,947 sharps injuries involving a source patient infected with a blood borne virus were reported by health care
workers, during 2002-2011 in England, Wales and Northern Ireland. Significant sharps injuries were 67% higher in 2011
compared to 2002. Nearly 40% of the injuries occur after use and before the sharp devices are disposed. 41% of the injuries
occur while sharp devices are used and 15% of injuries during disposal or after it.
Every minute, more than 10,000 venipunctures are being performed in the world. However, needles have not changed for
more than 150 years. The needle normally produces only transitory mild discomfort. However, from 3.5 to 10% of the
population suffer from belonephobia (extreme fear of needles) avoiding healthcare settings.
We are developing a needle-free solution which is able to extract, collect and analyse blood in a painless, safe an easy way.
Our approach enables monitoring of major global infectious diseases such as HIV, Malaria and Hepatitis which is key for a
sustainable elimination of such. SmartSyringe represents a breakthrough especially for blood collection in developing
countries. As almost no training is required for proper usage, facilitating diagnostics in areas where there is a lack of
healthcare professionals.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences infectious diseases malaria
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- engineering and technology medical engineering medical laboratory technology laboratory samples analysis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1095 LUTRY
Switzerland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.